{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:22:57Z","timestamp":1792790577008,"version":"4.5.0"},"reference-count":122,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T00:00:00Z","timestamp":1762387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T00:00:00Z","timestamp":1762387200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000053","name":"U.S. Department of Health & Human Services | NIH | National Eye Institute","doi-asserted-by":"publisher","award":["R01-EY027785"],"award-info":[{"award-number":["R01-EY027785"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008097","name":"Edward N. and Della L. Thome Memorial Foundation","doi-asserted-by":"publisher","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}],"id":[{"id":"10.13039\/100008097","id-type":"DOI","asserted-by":"publisher"}]},{"name":"UT Southwestern Peter O'Donnell Jr. Brain Institute, Sprouts Pilot Grant","id":[{"id":"https:\/\/ror.org\/05byvp690","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","award":["R01-DK125352"],"award-info":[{"award-number":["R01-DK125352"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","award":["R01-DK128031"],"award-info":[{"award-number":["R01-DK128031"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Chronic, unresolved inflammation has long been speculated to serve as an initiating and propagating factor in numerous neurodegenerative diseases, including a leading cause of irreversible blindness in the elderly, age-related macular degeneration (AMD). Intracellular multiprotein complexes called inflammasomes in combination with activated caspases facilitate production of pro-inflammatory cytokines such as interleukin 1 beta. Specifically, the nucleotide-binding oligomerization (NOD)-like receptor protein 3 (NLRP3) has received heightened attention due to the wide range of stimuli to which it can respond and its potential involvement in AMD. In this study, we directly tested the role of Nlrp3 and its downstream effector, caspase 1 (Casp1) in mediating early AMD-like pathology (i.e., basal laminar deposits [BLamDs]) in wild-type (WT) mice and the Malattia Leventinese\/Doyne honeycomb retinal dystrophy (ML\/DHRD) mouse model (p.R345W mutation in Efemp1). Compared to aged-matched controls, R345W\n                    <jats:sup>+\/+<\/jats:sup>\n                    knockin mice demonstrated increased Muller cell gliosis, subretinal Iba-1\n                    <jats:sup>+<\/jats:sup>\n                    cells, higher Nlrp3 immunoreactivity in the retina, as well as significant transcriptional upregulation of complement component 3, Nlrp3, pro-Il1b, pro-caspase-1, and tissue inhibitor of matrix metalloproteinase 3 in the retinal pigmented epithelium (RPE)\/choroid. These findings were accompanied by an age-related increase in BLamD formation in the R345W\n                    <jats:sup>+\/+<\/jats:sup>\n                    mice. Genetic elimination of either Nlrp3 or Casp1 significantly reduced both the size and coverage of BLamDs in the R345W\n                    <jats:sup>+\/+<\/jats:sup>\n                    background, highlighting an important and underappreciated pathway that could affect ML\/DHRD onset and progression. Moreover, Nlrp3 knockout reduced spontaneous, age-related BLamDs in WT mice, suggesting translatability of our findings not only to rare inherited retinal dystrophies, but also potentially to AMD itself.\n                  <\/jats:p>","DOI":"10.1038\/s41419-025-08104-y","type":"journal-article","created":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T15:35:20Z","timestamp":1762443320000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Genetic removal of Nlrp3 protects against age-related and R345W Efemp1-induced basal laminar deposit formation"],"prefix":"10.1038","volume":"16","author":[{"given":"Antonio J.","family":"Ortega","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steffi","family":"Daniel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marian","family":"Renwick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pravallika","family":"Kambhampati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krista N.","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gracen E.","family":"Collier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily L.","family":"Baker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9002-5399","authenticated-orcid":false,"given":"Hasan","family":"Zaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8149-656X","authenticated-orcid":false,"given":"John D.","family":"Hulleman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,6]]},"reference":[{"key":"8104_CR1","doi-asserted-by":"crossref","unstructured":"Fusco R, Siracusa R, Genovese T, Cuzzocrea S, Di Paola R. Focus on the role of NLRP3 inflammasome in diseases. Int J Mol Sci. 2020;21:4223.","DOI":"10.3390\/ijms21124223"},{"key":"8104_CR2","first-page":"575","volume":"4","author":"JW Kinney","year":"2018","unstructured":"Kinney JW, Bemiller SM, Murtishaw AS, Leisgang AM, Salazar AM, Lamb BT. Inflammation as a central mechanism in Alzheimer\u2019s disease. Alzheimers Dement. 2018;4:575\u201390.","journal-title":"Alzheimers Dement"},{"key":"8104_CR3","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1038\/s41577-022-00684-6","volume":"22","author":"MG Tansey","year":"2022","unstructured":"Tansey MG, Wallings RL, Houser MC, Herrick MK, Keating CE, Joers V. Inflammation and immune dysfunction in Parkinson disease. Nat Rev Immunol. 2022;22:657\u201373.","journal-title":"Nat Rev Immunol"},{"key":"8104_CR4","doi-asserted-by":"publisher","first-page":"246","DOI":"10.2174\/156652411795243450","volume":"11","author":"PA McCombe","year":"2011","unstructured":"McCombe PA, Henderson RD. The role of immune and inflammatory mechanisms in ALS. Curr Mol Med. 2011;11:246\u201354.","journal-title":"Curr Mol Med"},{"key":"8104_CR5","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1038\/nm1709","volume":"14","author":"JG Hollyfield","year":"2008","unstructured":"Hollyfield JG, Bonilha VL, Rayborn ME, Yang X, Shadrach KG, Lu L, et al. Oxidative damage-induced inflammation initiates age-related macular degeneration. Nat Med. 2008;14:194\u20138.","journal-title":"Nat Med"},{"key":"8104_CR6","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1167\/iovs.09-4481","volume":"51","author":"JG Hollyfield","year":"2010","unstructured":"Hollyfield JG. Age-related macular degeneration: the molecular link between oxidative damage, tissue-specific inflammation and outer retinal disease: the Proctor lecture. Investig Ophthalmol Vis Sci. 2010;51:1275\u201381.","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"8104_CR7","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1001\/jamaophthalmol.2013.7671","volume":"132","author":"R Klein","year":"2014","unstructured":"Klein R, Myers CE, Cruickshanks KJ, Gangnon RE, Danforth LG, Sivakumaran TA, et al. Markers of inflammation, oxidative stress, and endothelial dysfunction and the 20-year cumulative incidence of early age-related macular degeneration: the Beaver Dam Eye Study. JAMA Ophthalmol. 2014;132:446\u201355.","journal-title":"JAMA Ophthalmol"},{"key":"8104_CR8","doi-asserted-by":"publisher","first-page":"a016287","DOI":"10.1101\/cshperspect.a016287","volume":"6","author":"MR de Zoete","year":"2014","unstructured":"de Zoete MR, Palm NW, Zhu S, Flavell RA. Inflammasomes. Cold Spring Harb Perspect Biol. 2014;6:a016287.","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"8104_CR9","doi-asserted-by":"publisher","first-page":"36","DOI":"10.3389\/fimmu.2017.00036","volume":"8","author":"C Pellegrini","year":"2017","unstructured":"Pellegrini C, Antonioli L, Lopez-Castejon G, Blandizzi C, Fornai M. Canonical and non-canonical activation of NLRP3 inflammasome at the crossroad between immune tolerance and intestinal inflammation. Front Immunol. 2017;8:36.","journal-title":"Front Immunol"},{"key":"8104_CR10","doi-asserted-by":"publisher","first-page":"4126","DOI":"10.1167\/iovs.17-22133","volume":"58","author":"KT Vu","year":"2017","unstructured":"Vu KT, Zhang F, Hulleman JD. Conditional, genetically encoded, small molecule-regulated inhibition of NFkappaB signaling in RPE cells. Investig Ophthalmol Vis Sci. 2017;58:4126\u201337.","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"8104_CR11","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.exer.2017.08.001","volume":"164","author":"KT Vu","year":"2017","unstructured":"Vu KT, Hulleman JD. An inducible form of Nrf2 confers enhanced protection against acute oxidative stresses in RPE cells. Exp Eye Res. 2017;164:31\u20136.","journal-title":"Exp Eye Res"},{"key":"8104_CR12","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1016\/j.immuni.2016.01.012","volume":"44","author":"MM Gaidt","year":"2016","unstructured":"Gaidt MM, Ebert TS, Chauhan D, Schmidt T, Schmid-Burgk JL, Rapino F, et al. Human monocytes engage an alternative inflammasome pathway. Immunity. 2016;44:833\u201346.","journal-title":"Immunity"},{"key":"8104_CR13","doi-asserted-by":"publisher","first-page":"2324","DOI":"10.1182\/blood-2008-03-146720","volume":"113","author":"MG Netea","year":"2009","unstructured":"Netea MG, Nold-Petry CA, Nold MF, Joosten LA, Opitz B, van der Meer JH, et al. Differential requirement for the activation of the inflammasome for processing and release of IL-1beta in monocytes and macrophages. Blood. 2009;113:2324\u201335.","journal-title":"Blood"},{"key":"8104_CR14","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1073\/pnas.1320294111","volume":"111","author":"KM Lin","year":"2014","unstructured":"Lin KM, Hu W, Troutman TD, Jennings M, Brewer T, Li X, et al. IRAK-1 bypasses priming and directly links TLRs to rapid NLRP3 inflammasome activation. Proc Natl Acad Sci USA. 2014;111:775\u201380.","journal-title":"Proc Natl Acad Sci USA"},{"key":"8104_CR15","doi-asserted-by":"publisher","first-page":"173","DOI":"10.4142\/jvs.2014.15.2.173","volume":"15","author":"Z Huang","year":"2014","unstructured":"Huang Z, Yu M, Tong S, Jia K, Liu R, Wang H, et al. Tissue-specific expression of the NOD-like receptor protein 3 in BALB\/c mice. J Vet Sci. 2014;15:173\u20137.","journal-title":"J Vet Sci"},{"key":"8104_CR16","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/s41531-018-0061-5","volume":"4","author":"KM von Herrmann","year":"2018","unstructured":"von Herrmann KM, Salas LA, Martinez EM, Young AL, Howard JM, Feldman MS, et al. NLRP3 expression in mesencephalic neurons and characterization of a rare NLRP3 polymorphism associated with decreased risk of Parkinson\u2019s disease. NPJ Parkinsons Dis. 2018;4:24.","journal-title":"NPJ Parkinsons Dis"},{"key":"8104_CR17","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1038\/s41419-018-0764-x","volume":"9","author":"F Lebreton","year":"2018","unstructured":"Lebreton F, Berishvili E, Parnaud G, Rouget C, Bosco D, Berney T, et al. NLRP3 inflammasome is expressed and regulated in human islets. Cell Death Dis. 2018;9:726.","journal-title":"Cell Death Dis"},{"key":"8104_CR18","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1167\/iovs.12-10655","volume":"54","author":"WA Tseng","year":"2013","unstructured":"Tseng WA, Thein T, Kinnunen K, Lashkari K, Gregory MS, D\u2019Amore PA, et al. NLRP3 inflammasome activation in retinal pigment epithelial cells by lysosomal destabilization: implications for age-related macular degeneration. Investig Ophthalmol Vis Sci. 2013;54:110\u201320.","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"8104_CR19","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1016\/j.cell.2012.03.036","volume":"149","author":"V Tarallo","year":"2012","unstructured":"Tarallo V, Hirano Y, Gelfand BD, Dridi S, Kerur N, Kim Y, et al. DICER1 loss and Alu RNA induce age-related macular degeneration via the NLRP3 inflammasome and MyD88. Cell. 2012;149:847\u201359.","journal-title":"Cell"},{"key":"8104_CR20","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1038\/s41421-020-0167-x","volume":"6","author":"D Zheng","year":"2020","unstructured":"Zheng D, Liwinski T, Elinav E. Inflammasome activation and regulation: toward a better understanding of complex mechanisms. Cell Discov. 2020;6:36.","journal-title":"Cell Discov"},{"key":"8104_CR21","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/nrmicro2070","volume":"7","author":"T Bergsbaken","year":"2009","unstructured":"Bergsbaken T, Fink SL, Cookson BT. Pyroptosis: host cell death and inflammation. Nat Rev Microbiol. 2009;7:99\u2013109.","journal-title":"Nat Rev Microbiol"},{"key":"8104_CR22","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3389\/fmicb.2011.00012","volume":"2","author":"PK Anand","year":"2011","unstructured":"Anand PK, Malireddi RK, Kanneganti TD. Role of the nlrp3 inflammasome in microbial infection. Front Microbiol. 2011;2:12.","journal-title":"Front Microbiol"},{"key":"8104_CR23","doi-asserted-by":"publisher","first-page":"643254","DOI":"10.3389\/fphar.2021.643254","volume":"12","author":"JA Holbrook","year":"2021","unstructured":"Holbrook JA, Jarosz-Griffiths HH, Caseley E, Lara-Reyna S, Poulter JA, CH Williams-Gray, et al. Neurodegenerative disease and the NLRP3 inflammasome. Front Pharm. 2021;12:643254.","journal-title":"Front Pharm"},{"key":"8104_CR24","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.845185","volume":"13","author":"T Liang","year":"2022","unstructured":"Liang T, Zhang Y, Wu S, Chen Q, Wang L. The role of NLRP3 inflammasome in Alzheimer\u2019s disease and potential therapeutic targets. Front Pharm. 2022;13:845185.","journal-title":"Front Pharm"},{"key":"8104_CR25","doi-asserted-by":"publisher","first-page":"2117","DOI":"10.3233\/JPD-223290","volume":"12","author":"LTN Nguyen","year":"2022","unstructured":"Nguyen LTN, Nguyen HD, Kim YJ, Nguyen TT, Lai TT, Lee YK, et al. Role of NLRP3 inflammasome in Parkinson\u2019s disease and therapeutic considerations. J Parkinsons Dis. 2022;12:2117\u201333.","journal-title":"J Parkinsons Dis"},{"key":"8104_CR26","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1002\/glia.23728","volume":"68","author":"V Deora","year":"2020","unstructured":"Deora V, Lee JD, Albornoz EA, McAlary L, Jagaraj CJ, Robertson AAB, et al. The microglial NLRP3 inflammasome is activated by amyotrophic lateral sclerosis proteins. Glia. 2020;68:407\u201321.","journal-title":"Glia"},{"key":"8104_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2023.101954","volume":"88","author":"JJ Maran","year":"2023","unstructured":"Maran JJ, Adesina MM, Green CR, Kwakowsky A, Mugisho OO. The central role of the NLRP3 inflammasome pathway in the pathogenesis of age-related diseases in the eye and the brain. Ageing Res Rev. 2023;88:101954.","journal-title":"Ageing Res Rev"},{"key":"8104_CR28","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1001\/jama.2023.26074","volume":"331","author":"M Fleckenstein","year":"2024","unstructured":"Fleckenstein M, Schmitz-Valckenberg S, Chakravarthy U. Age-related macular degeneration: a review. JAMA. 2024;331:147\u201357.","journal-title":"JAMA"},{"key":"8104_CR29","doi-asserted-by":"publisher","first-page":"E106","DOI":"10.1016\/S2214-109X(13)70145-1","volume":"2","author":"WL Wong","year":"2014","unstructured":"Wong WL, Su XY, Li X, Cheung CMG, Klein R, Cheng CY, et al. Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis. Lancet Glob Health. 2014;2:E106\u2013E116.","journal-title":"Lancet Glob Health"},{"key":"8104_CR30","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1056\/NEJMra062326","volume":"355","author":"PT de Jong","year":"2006","unstructured":"de Jong PT. Age-related macular degeneration. N Engl J Med. 2006;355:1474\u201385.","journal-title":"N Engl J Med"},{"key":"8104_CR31","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/s41572-021-00265-2","volume":"7","author":"M Fleckenstein","year":"2021","unstructured":"Fleckenstein M, Keenan TDL, Guymer RH, Chakravarthy U, Schmitz-Valckenberg S, Klaver CC, et al. Age-related macular degeneration. Nat Rev Dis Prim. 2021;7:31.","journal-title":"Nat Rev Dis Prim"},{"key":"8104_CR32","doi-asserted-by":"publisher","first-page":"E4069","DOI":"10.1073\/pnas.1307574110","volume":"110","author":"P Hu","year":"2013","unstructured":"Hu P, Herrmann R, Bednar A, Saloupis P, Dwyer MA, Yang P, et al. Aryl hydrocarbon receptor deficiency causes dysregulated cellular matrix metabolism and age-related macular degeneration-like pathology. Proc Natl Acad Sci USA. 2013;110:E4069\u20134078.","journal-title":"Proc Natl Acad Sci USA"},{"key":"8104_CR33","doi-asserted-by":"crossref","unstructured":"Artlett CM. The mechanism and regulation of the NLRP3 inflammasome during fibrosis. Biomolecules. 2022;12:634.","DOI":"10.3390\/biom12050634"},{"key":"8104_CR34","doi-asserted-by":"publisher","first-page":"80","DOI":"10.2174\/1874312901206010080","volume":"6","author":"CM Artlett","year":"2012","unstructured":"Artlett CM. The role of the NLRP3 inflammasome in fibrosis. Open Rheumatol J. 2012;6:80\u201386.","journal-title":"Open Rheumatol J"},{"key":"8104_CR35","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.redox.2015.01.008","volume":"4","author":"A Abderrazak","year":"2015","unstructured":"Abderrazak A, Syrovets T, Couchie D, El Hadri K, Friguet B, Simmet T, et al. NLRP3 inflammasome: from a danger signal sensor to a regulatory node of oxidative stress and inflammatory diseases. Redox Biol. 2015;4:296\u2013307.","journal-title":"Redox Biol"},{"key":"8104_CR36","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1016\/j.it.2021.07.005","volume":"42","author":"JJ Liang","year":"2021","unstructured":"Liang JJ, Fraser IDC, Bryant CE. Lipid regulation of NLRP3 inflammasome activity through organelle stress. Trends Immunol. 2021;42:807\u201323.","journal-title":"Trends Immunol"},{"key":"8104_CR37","doi-asserted-by":"publisher","first-page":"7395","DOI":"10.1167\/iovs.13-12500","volume":"54","author":"N Kerur","year":"2013","unstructured":"Kerur N, Hirano Y, Tarallo V, Fowler BJ, Bastos-Carvalho A, Yasuma T, et al. TLR-independent and P2X7-dependent signaling mediate Alu RNA-induced NLRP3 inflammasome activation in geographic atrophy. Investig Ophthalmol Vis Sci. 2013;54:7395\u2013401.","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"8104_CR38","doi-asserted-by":"crossref","unstructured":"Ambati M, Apicella I, Wang SB, Narendran S, Leung H, Pereira F, et al. Identification of fluoxetine as a direct NLRP3 inhibitor to treat atrophic macular degeneration. Proc Natl Acad Sci USA. 2021;118:e2102975118.","DOI":"10.1073\/pnas.2102975118"},{"key":"8104_CR39","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1038\/nri3459","volume":"13","author":"J Ambati","year":"2013","unstructured":"Ambati J, Atkinson JP, Gelfand BD. Immunology of age-related macular degeneration. Nat Rev Immunol. 2013;13:438\u201351.","journal-title":"Nat Rev Immunol"},{"key":"8104_CR40","doi-asserted-by":"publisher","first-page":"230ra244","DOI":"10.1126\/scitranslmed.3007616","volume":"6","author":"SL Doyle","year":"2014","unstructured":"Doyle SL, Ozaki E, Brennan K, Humphries MM, Mulfaul K, Keaney J, et al. IL-18 attenuates experimental choroidal neovascularization as a potential therapy for wet age-related macular degeneration. Sci Transl Med. 2014;6:230ra244.","journal-title":"Sci Transl Med"},{"key":"8104_CR41","doi-asserted-by":"publisher","first-page":"5424","DOI":"10.1167\/iovs.15-17264","volume":"56","author":"SL Doyle","year":"2015","unstructured":"Doyle SL, Lopez FJ, Celkova L, Brennan K, Mulfaul K, Ozaki E, et al. IL-18 Immunotherapy for neovascular AMD: tolerability and efficacy in nonhuman primates. Investig Ophthalmol Vis Sci. 2015;56:5424\u201330.","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"8104_CR42","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1038\/nm.2717","volume":"18","author":"SL Doyle","year":"2012","unstructured":"Doyle SL, Campbell M, Ozaki E, Salomon RG, Mori A, Kenna PF, et al. NLRP3 has a protective role in age-related macular degeneration through the induction of IL-18 by drusen components. Nat Med. 2012;18:791\u20138.","journal-title":"Nat Med"},{"key":"8104_CR43","doi-asserted-by":"publisher","first-page":"172","DOI":"10.3390\/jcm4010172","volume":"4","author":"L Celkova","year":"2015","unstructured":"Celkova L, Doyle SL, Campbell M. NLRP3 inflammasome and pathobiology in AMD. J Clin Med. 2015;4:172\u201392.","journal-title":"J Clin Med"},{"key":"8104_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.exer.2020.108384","volume":"202","author":"HH Louie","year":"2021","unstructured":"Louie HH, Shome A, Kuo CY, Rupenthal ID, Green CR, Mugisho OO. Connexin43 hemichannel block inhibits NLRP3 inflammasome activation in a human retinal explant model of diabetic retinopathy. Exp Eye Res. 2021;202:108384.","journal-title":"Exp Eye Res"},{"key":"8104_CR45","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1080\/09273948.2020.1811350","volume":"30","author":"KS Raman","year":"2022","unstructured":"Raman KS, Matsubara JA. Dysregulation of the NLRP3 inflammasome in diabetic retinopathy and potential therapeutic targets. Ocul Immunol Inflamm. 2022;30:470\u20138.","journal-title":"Ocul Immunol Inflamm"},{"key":"8104_CR46","doi-asserted-by":"publisher","first-page":"1877","DOI":"10.1080\/09273948.2022.2113804","volume":"31","author":"B Li","year":"2023","unstructured":"Li B, Yang Z, Zhao X, Chen Y, Li D, Zhang L, et al. Early onset drusen and RPE dysfunction in a patient with NLRP3-AID. Ocul Immunol Inflamm. 2023;31:1877\u201380.","journal-title":"Ocul Immunol Inflamm"},{"key":"8104_CR47","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-79570-x","volume":"11","author":"DR Woodard","year":"2021","unstructured":"Woodard DR, Nakahara E, Hulleman JD. Clinically-identified C-terminal mutations in fibulin-3 are prone to misfolding and destabilization. Sci Rep. 2021;11:2998.","journal-title":"Sci Rep"},{"key":"8104_CR48","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.exer.2014.12.002","volume":"130","author":"A Nguyen","year":"2015","unstructured":"Nguyen A, Hulleman JD. Differential tolerance of \u2018pseudo-pathogenic\u2019 tryptophan residues in calcium-binding EGF domains of short fibulin proteins. Exp Eye Res. 2015;130:66\u201372.","journal-title":"Exp Eye Res"},{"key":"8104_CR49","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1096\/fj.14-255414","volume":"29","author":"JD Hulleman","year":"2015","unstructured":"Hulleman JD, Kelly JW. Genetic ablation of N-linked glycosylation reveals two key folding pathways for R345W fibulin-3, a secreted protein associated with retinal degeneration. FASEB J. 2015;29:565\u201375.","journal-title":"FASEB J"},{"key":"8104_CR50","doi-asserted-by":"publisher","first-page":"4765","DOI":"10.1091\/mbc.e11-08-0695","volume":"22","author":"JD Hulleman","year":"2011","unstructured":"Hulleman JD, Kaushal S, Balch WE, Kelly JW. Compromised mutant EFEMP1 secretion associated with macular dystrophy remedied by proteostasis network alteration. Mol Biol Cell. 2011;22:4765\u201375.","journal-title":"Mol Biol Cell"},{"key":"8104_CR51","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.exer.2016.10.017","volume":"153","author":"JD Hulleman","year":"2016","unstructured":"Hulleman JD, Genereux JC, Nguyen A. Mapping wild-type and R345W fibulin-3 intracellular interactomes. Exp Eye Res. 2016;153:165\u20139.","journal-title":"Exp Eye Res"},{"key":"8104_CR52","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1177\/1087057112469405","volume":"18","author":"JD Hulleman","year":"2013","unstructured":"Hulleman JD, Brown SJ, Rosen H, Kelly JW. A high-throughput cell-based Gaussia luciferase reporter assay for identifying modulators of fibulin-3 secretion. J Biomol Screen. 2013;18:647\u201358.","journal-title":"J Biomol Screen"},{"key":"8104_CR53","doi-asserted-by":"publisher","first-page":"4548","DOI":"10.1096\/fj.11-202861","volume":"26","author":"JD Hulleman","year":"2012","unstructured":"Hulleman JD, Balch WE, Kelly JW. Translational attenuation differentially alters the fate of disease-associated fibulin proteins. FASEB J. 2012;26:4548\u201360.","journal-title":"FASEB J"},{"key":"8104_CR54","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/978-3-319-17121-0_21","volume":"854","author":"JD Hulleman","year":"2016","unstructured":"Hulleman JD. Malattia Leventinese\/Doyne Honeycomb retinal dystrophy: similarities to age-related macular degeneration and potential therapies. Adv Exp Med Biol. 2016;854:153\u20138.","journal-title":"Adv Exp Med Biol"},{"key":"8104_CR55","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1007\/s00109-020-01974-z","volume":"98","author":"S Daniel","year":"2020","unstructured":"Daniel S, Renwick M, Chau VQ, Datta S, Maddineni P, Zode G, et al. Fibulin-3 knockout mice demonstrate corneal dysfunction but maintain normal retinal integrity. J Mol Med. 2020;98:1639\u201356.","journal-title":"J Mol Med"},{"key":"8104_CR56","doi-asserted-by":"crossref","unstructured":"Daniel S, Hulleman JD. Important anatomical, age-related, and species considerations regarding ocular fibulin-3 (EFEMP1) analysis. Biochim Biophys Acta Mol Basis Dis. 2024;1870:167239.","DOI":"10.1016\/j.bbadis.2024.167239"},{"key":"8104_CR57","doi-asserted-by":"publisher","first-page":"e178050","DOI":"10.1172\/jci.insight.178050","volume":"9","author":"SM DiCesare","year":"2024","unstructured":"DiCesare SM, Ortega AJ, Collier GE, Daniel S, Thompson KN, McCoy MK. et al. GSK3 inhibition reduces ECM production and prevents age-related macular degeneration-like pathology. JCI Insight. JCI Insight. 2024;9:e178050","journal-title":"JCI Insight"},{"key":"8104_CR58","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1016\/j.ajhg.2021.04.006","volume":"108","author":"YT Tsai","year":"2021","unstructured":"Tsai YT, Li Y, Ryu J, Su PY, Cheng CH, Wu WH, et al. Impaired cholesterol efflux in retinal pigment epithelium of individuals with juvenile macular degeneration. Am J Hum Genet. 2021;108:903\u201318.","journal-title":"Am J Hum Genet"},{"key":"8104_CR59","doi-asserted-by":"publisher","DOI":"10.1111\/acel.12710","volume":"17","author":"MK Lin","year":"2018","unstructured":"Lin MK, Yang J, Hsu CW, Gore A, Bassuk AG, Brown LM, et al. HTRA1, an age-related macular degeneration protease, processes extracellular matrix proteins EFEMP1 and TSP1. Aging Cell. 2018;17:e12710.","journal-title":"Aging Cell"},{"key":"8104_CR60","doi-asserted-by":"publisher","DOI":"10.1002\/jev2.12373","volume":"12","author":"M Zhou","year":"2023","unstructured":"Zhou M, Zhao Y, Weber SR, Gates C, Carruthers NJ, Chen H, et al. Extracellular vesicles from retinal pigment epithelial cells expressing R345W-Fibulin-3 induce epithelial-mesenchymal transition in recipient cells. J Extracell Vesicles. 2023;12:e12373.","journal-title":"J Extracell Vesicles"},{"key":"8104_CR61","doi-asserted-by":"publisher","first-page":"469","DOI":"10.3389\/fcell.2020.00469","volume":"8","author":"M Zhou","year":"2020","unstructured":"Zhou M, Weber SR, Zhao Y, Chen H, Barber AJ, Grillo SL, et al. Expression of R345W-Fibulin-3 induces epithelial-mesenchymal transition in retinal pigment epithelial cells. Front Cell Dev Biol. 2020;8:469.","journal-title":"Front Cell Dev Biol"},{"key":"8104_CR62","doi-asserted-by":"publisher","DOI":"10.1016\/j.exer.2020.108422","volume":"203","author":"SL Grillo","year":"2021","unstructured":"Grillo SL, Etzel JD, Weber SR, Ondeck C, Wang W, Zhao Y, et al. Descriptive analysis of Fibulin-3 and the extracellular vesicle marker, Alix, in drusen from a small cohort of postmortem human eyes. Exp Eye Res. 2021;203:108422.","journal-title":"Exp Eye Res"},{"key":"8104_CR63","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.exer.2009.09.018","volume":"90","author":"Y Zhang","year":"2010","unstructured":"Zhang Y, Marmorstein LY. Focus on molecules: fibulin-3 (EFEMP1). Exp Eye Res. 2010;90:374\u20135.","journal-title":"Exp Eye Res"},{"key":"8104_CR64","doi-asserted-by":"publisher","first-page":"3046","DOI":"10.1167\/iovs.17-21720","volume":"58","author":"A Zayas-Santiago","year":"2017","unstructured":"Zayas-Santiago A, Cross SD, Stanton JB, Marmorstein AD, Marmorstein LY. Mutant Fibulin-3 causes proteoglycan accumulation and impaired diffusion across Bruch\u2019s membrane. Investig Ophthalmol Vis Sci. 2017;58:3046\u201354.","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"8104_CR65","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1167\/iovs.16-20955","volume":"58","author":"JB Stanton","year":"2017","unstructured":"Stanton JB, Marmorstein AD, Zhang Y, Marmorstein LY. Deletion of Efemp1 Is protective against the development of Sub-RPE deposits in mouse eyes. Investig Ophthalmol Vis Sci. 2017;58:1455\u201361.","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"8104_CR66","doi-asserted-by":"publisher","first-page":"3059","DOI":"10.1093\/hmg\/ddm264","volume":"16","author":"PJ McLaughlin","year":"2007","unstructured":"McLaughlin PJ, Bakall B, Choi J, Liu Z, Sasaki T, Davis EC, et al. Lack of fibulin-3 causes early aging and herniation, but not macular degeneration in mice. Hum Mol Genet. 2007;16:3059\u201370.","journal-title":"Hum Mol Genet"},{"key":"8104_CR67","doi-asserted-by":"publisher","first-page":"2423","DOI":"10.1093\/hmg\/ddm199","volume":"16","author":"LY Marmorstein","year":"2007","unstructured":"Marmorstein LY, McLaughlin PJ, Peachey NS, Sasaki T, Marmorstein AD. Formation and progression of sub-retinal pigment epithelium deposits in Efemp1 mutation knock-in mice: a model for the early pathogenic course of macular degeneration. Hum Mol Genet. 2007;16:2423\u201332.","journal-title":"Hum Mol Genet"},{"key":"8104_CR68","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1080\/13816810490498305","volume":"25","author":"L Marmorstein","year":"2004","unstructured":"Marmorstein L. Association of EFEMP1 with malattia leventinese and age-related macular degeneration: a mini-review. Ophthalmic Genet. 2004;25:219\u201326.","journal-title":"Ophthalmic Genet"},{"key":"8104_CR69","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1093\/hmg\/ddx392","volume":"27","author":"R Fernandez-Godino","year":"2018","unstructured":"Fernandez-Godino R, Bujakowska KM, Pierce EA. Changes in extracellular matrix cause RPE cells to make basal deposits and activate the alternative complement pathway. Hum Mol Genet. 2018;27:147\u201359.","journal-title":"Hum Mol Genet"},{"key":"8104_CR70","doi-asserted-by":"publisher","first-page":"5555","DOI":"10.1093\/hmg\/ddv287","volume":"24","author":"R Fernandez-Godino","year":"2015","unstructured":"Fernandez-Godino R, Garland DL, Pierce EA. A local complement response by RPE causes early-stage macular degeneration. Hum Mol Genet. 2015;24:5555\u201369.","journal-title":"Hum Mol Genet"},{"key":"8104_CR71","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-28143-0","volume":"8","author":"R Fernandez-Godino","year":"2018","unstructured":"Fernandez-Godino R, Pierce EA. C3a triggers formation of sub-retinal pigment epithelium deposits via the ubiquitin proteasome pathway. Sci Rep. 2018;8:9679.","journal-title":"Sci Rep"},{"key":"8104_CR72","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/978-3-319-17121-0_8","volume":"854","author":"R Fernandez-Godino","year":"2016","unstructured":"Fernandez-Godino R, Pierce EA, Garland DL. Extracellular matrix alterations and deposit formation in AMD. Adv Exp Med Biol. 2016;854:53\u201358.","journal-title":"Adv Exp Med Biol"},{"key":"8104_CR73","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1038\/9722","volume":"22","author":"EM Stone","year":"1999","unstructured":"Stone EM, Lotery AJ, Munier FL, Heon E, Piguet B, Guymer RH, et al. A single EFEMP1 mutation associated with both Malattia Leventinese and Doyne honeycomb retinal dystrophy. Nat Genet. 1999;22:199\u2013202.","journal-title":"Nat Genet"},{"key":"8104_CR74","doi-asserted-by":"publisher","first-page":"3085","DOI":"10.1167\/iovs.05-1600","volume":"47","author":"M Michaelides","year":"2006","unstructured":"Michaelides M, Jenkins SA, Brantley MA Jr., Andrews, Waseem RM, Luong N, et al. Maculopathy due to the R345W substitution in fibulin-3: distinct clinical features, disease variability, and extent of retinal dysfunction. Investig Ophthalmol Vis Sci. 2006;47:3085\u201397.","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"8104_CR75","doi-asserted-by":"publisher","first-page":"2411","DOI":"10.1093\/hmg\/ddm198","volume":"16","author":"L Fu","year":"2007","unstructured":"Fu L, Garland D, Yang Z, Shukla D, Rajendran A, Pearson E, et al. The R345W mutation in EFEMP1 is pathogenic and causes AMD-like deposits in mice. Hum Mol Genet. 2007;16:2411\u201322.","journal-title":"Hum Mol Genet"},{"key":"8104_CR76","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-89978-8","volume":"11","author":"DL Garland","year":"2021","unstructured":"Garland DL, Pierce EA, Fernandez-Godino R. Complement C5 is not critical for the formation of sub-RPE deposits in Efemp1 mutant mice. Sci Rep. 2021;11:10416.","journal-title":"Sci Rep"},{"key":"8104_CR77","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1093\/hmg\/ddt395","volume":"23","author":"DL Garland","year":"2014","unstructured":"Garland DL, Fernandez-Godino R, Kaur I, Speicher KD, Harnly JM, Lambris JD, et al. Mouse genetics and proteomic analyses demonstrate a critical role for complement in a model of DHRD\/ML, an inherited macular degeneration. Hum Mol Genet. 2014;23:52\u201368.","journal-title":"Hum Mol Genet"},{"key":"8104_CR78","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/978-3-319-75402-4_4","volume":"1074","author":"R Fernandez-Godino","year":"2018","unstructured":"Fernandez-Godino R. Alterations in extracellular matrix\/Bruch\u2019s membrane can cause the activation of the alternative complement pathway via tick-over. Adv Exp Med Biol. 2018;1074:29\u201335.","journal-title":"Adv Exp Med Biol"},{"key":"8104_CR79","doi-asserted-by":"crossref","unstructured":"Crowley MA, Garland DL, Sellner H, Banks A, Fan L, Rejtar T, et al. Complement factor B is critical for sub-RPE deposit accumulation in a model of Doyne honeycomb retinal dystrophy with features of age-related macular degeneration. Human Mol Genet. 2022;32:204\u201317.","DOI":"10.1093\/hmg\/ddac187"},{"key":"8104_CR80","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1167\/iovs.61.13.19","volume":"61","author":"AA Sura","year":"2020","unstructured":"Sura AA, Chen L, Messinger JD, Swain TA, McGwin G Jr., Freund KB, et al. Measuring the contributions of basal laminar deposit and Bruch\u2019s membrane in age-related macular degeneration. Investig Ophthalmol Vis Sci. 2020;61:19.","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"8104_CR81","doi-asserted-by":"publisher","first-page":"2000","DOI":"10.1126\/science.7535475","volume":"267","author":"K Kuida","year":"1995","unstructured":"Kuida K, Lippke JA, Ku G, Harding MW, Livingston DJ, Su MS, et al. Altered cytokine export and apoptosis in mice deficient in interleukin-1 beta converting enzyme. Science. 1995;267:2000\u20133.","journal-title":"Science"},{"key":"8104_CR82","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2117553119","volume":"119","author":"D Ortolan","year":"2022","unstructured":"Ortolan D, Sharma R, Volkov A, Maminishkis A, Hotaling NA, Huryn LA, et al. Single-cell-resolution map of human retinal pigment epithelium helps discover subpopulations with differential disease sensitivity. Proc Natl Acad Sci USA. 2022;119:e2117553119.","journal-title":"Proc Natl Acad Sci USA"},{"key":"8104_CR83","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1172\/JCI131187","volume":"130","author":"NJ Schaub","year":"2020","unstructured":"Schaub NJ, Hotaling NA, Manescu P, Padi S, Wan Q, Sharma R, et al. Deep learning predicts function of live retinal pigment epithelium from quantitative microscopy. J Clin Investig. 2020;130:1010\u201323.","journal-title":"J Clin Investig"},{"key":"8104_CR84","first-page":"428","volume":"21","author":"N Sun","year":"2015","unstructured":"Sun N, Shibata B, Hess JF, FitzGerald PG. An alternative means of retaining ocular structure and improving immunoreactivity for light microscopy studies. Mol Vis. 2015;21:428\u201342.","journal-title":"Mol Vis"},{"key":"8104_CR85","doi-asserted-by":"crossref","unstructured":"Daniel S, Hulleman JD. Exploring ocular fibulin-3 (EFEMP1): anatomical, age-related, and species perspectives. Biochim Biophys Acta Mol Basis Dis. 2024;1870:167239.","DOI":"10.1016\/j.bbadis.2024.167239"},{"key":"8104_CR86","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2022.104206","volume":"25","author":"H Peng","year":"2022","unstructured":"Peng H, Ramadurgum P, Woodard DR, Daniel S, Nakahara E, Renwick M, et al. Utility of the DHFR-based destabilizing domain across mouse models of retinal degeneration and aging. iScience. 2022;25:104206.","journal-title":"iScience"},{"key":"8104_CR87","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1007\/BF02154735","volume":"224","author":"KU Loffler","year":"1986","unstructured":"Loffler KU, Lee WR. Basal linear deposit in the human macula. Graefe\u2019s Arch Clin Exp Ophthalmol. 1986;224:493\u2013501.","journal-title":"Graefe\u2019s Arch Clin Exp Ophthalmol"},{"key":"8104_CR88","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1159\/000187632","volume":"190","author":"E Reale","year":"2009","unstructured":"Reale E, Groos S, Eckardt U, Eckardt C, Luciano L. New components of \u2018basal laminar deposits\u2019 in age-related macular degeneration. Cells Tissues Organs. 2009;190:170\u201381.","journal-title":"Cells Tissues Organs"},{"key":"8104_CR89","doi-asserted-by":"crossref","unstructured":"Collantes ERA, Delfin MS, Fan B, Torregosa JMR, Siguan-Bell C, Florcruz NVG, et al. EFEMP1 rare variants cause familial juvenile-onset open-angle glaucoma. Hum Mutat. 2021;43:240\u201352.","DOI":"10.1002\/humu.24320"},{"key":"8104_CR90","doi-asserted-by":"publisher","first-page":"e0132529","DOI":"10.1371\/journal.pone.0132529","volume":"10","author":"DS Mackay","year":"2015","unstructured":"Mackay DS, Bennett TM, Shiels A. Exome sequencing identifies a missense variant in EFEMP1 Co-segregating in a family with autosomal dominant primary open-angle glaucoma. PLoS ONE. 2015;10:e0132529.","journal-title":"PLoS ONE"},{"key":"8104_CR91","doi-asserted-by":"crossref","unstructured":"Gupta V, Somarajan BI, Gupta S, Mahalingam K, Kumar M, Singh A. Association of EFEMP1 with juvenile-onset open angle glaucoma in a patient with concomitant COL11A1-related Stickler syndrome. Ophthalmic Genet. 2022;44:1\u20135.","DOI":"10.1080\/13816810.2022.2109682"},{"key":"8104_CR92","doi-asserted-by":"publisher","DOI":"10.1186\/s12886-018-0988-7","volume":"18","author":"K Zhang","year":"2018","unstructured":"Zhang K, Sun X, Chen Y, Zhong Q, Lin L, Gao Y, et al. Doyne honeycomb retinal dystrophy\/malattia leventinese induced by EFEMP1 mutation in a Chinese family. BMC Ophthalmol. 2018;18:318.","journal-title":"BMC Ophthalmol"},{"key":"8104_CR93","doi-asserted-by":"crossref","unstructured":"Chacon-Camacho OF, Ordaz-Robles T, Cid-Garcia MA, Yepes-Rodriguez O, Arce-Gonzalez R, Martinez-Aguilar A, et al. A new ocular phenotype combining juvenile glaucoma and doyne honeycomb retinal dystrophy (Malattia Leventinese) due to a Novel EFEMP1 pathogenic variant. Am J Med Genet Part A. 2024;197:e63869.","DOI":"10.1002\/ajmg.a.63869"},{"key":"8104_CR94","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1038\/nrn3723","volume":"15","author":"D Goldman","year":"2014","unstructured":"Goldman D. Muller glial cell reprogramming and retina regeneration. Nat Rev Neurosci. 2014;15:431\u201342.","journal-title":"Nat Rev Neurosci"},{"key":"8104_CR95","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1167\/iovs.09-4159","volume":"51","author":"N Lindqvist","year":"2010","unstructured":"Lindqvist N, Liu Q, Zajadacz J, Franze K, Reichenbach A. Retinal glial (Muller) cells: sensing and responding to tissue stretch. Investig Ophthalmol Vis Sci. 2010;51:1683\u201390.","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"8104_CR96","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1006897","volume":"13","author":"E Murenu","year":"2022","unstructured":"Murenu E, Gerhardt MJ, Biel M, Michalakis S. More than meets the eye: the role of microglia in healthy and diseased retina. Front Immunol. 2022;13:1006897.","journal-title":"Front Immunol"},{"key":"8104_CR97","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.tins.2020.03.012","volume":"43","author":"C Yu","year":"2020","unstructured":"Yu C, Roubeix C, Sennlaub F, Saban DR. Microglia versus monocytes: distinct roles in degenerative diseases of the retina. Trends Neurosci. 2020;43:433\u201349.","journal-title":"Trends Neurosci"},{"key":"8104_CR98","doi-asserted-by":"publisher","DOI":"10.1186\/1742-2094-11-12","volume":"11","author":"SG Torres-Platas","year":"2014","unstructured":"Torres-Platas SG, Comeau S, Rachalski A, Bo GD, Cruceanu C, Turecki G, et al. Morphometric characterization of microglial phenotypes in human cerebral cortex. J Neuroinflamm. 2014;11:12.","journal-title":"J Neuroinflamm"},{"key":"8104_CR99","doi-asserted-by":"crossref","unstructured":"Lier J, Streit WJ, Bechmann I. Beyond activation: characterizing microglial functional phenotypes. Cells. 2021;10:2236.","DOI":"10.3390\/cells10092236"},{"key":"8104_CR100","doi-asserted-by":"publisher","first-page":"2006","DOI":"10.4049\/jimmunol.1201065","volume":"189","author":"M Kovarova","year":"2012","unstructured":"Kovarova M, Hesker PR, Jania L, Nguyen M, Snouwaert JN, Xiang Z, et al. NLRP1-dependent pyroptosis leads to acute lung injury and morbidity in mice. J Immunol. 2012;189:2006\u201316.","journal-title":"J Immunol"},{"key":"8104_CR101","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.immuni.2010.03.003","volume":"32","author":"MH Zaki","year":"2010","unstructured":"Zaki MH, Boyd KL, Vogel P, Kastan MB, Lamkanfi M, Kanneganti TD. The NLRP3 inflammasome protects against loss of epithelial integrity and mortality during experimental colitis. Immunity. 2010;32:379\u201391.","journal-title":"Immunity"},{"key":"8104_CR102","doi-asserted-by":"publisher","first-page":"16955","DOI":"10.1074\/jbc.M112.358705","volume":"287","author":"Z Liu","year":"2012","unstructured":"Liu Z, Zaki MH, Vogel P, Gurung P, Finlay BB, Deng W, et al. Role of inflammasomes in host defense against Citrobacter rodentium infection. J Biol Chem. 2012;287:16955\u201364.","journal-title":"J Biol Chem"},{"key":"8104_CR103","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.chembiol.2023.09.016","volume":"31","author":"KA Teske","year":"2024","unstructured":"Teske KA, Corona C, Wilkinson J, Mamott D, Good DA, Zambrano D, et al. Interrogating direct NLRP3 engagement and functional inflammasome inhibition using cellular assays. Cell Chem Biol. 2024;31:349\u201360.e346.","journal-title":"Cell Chem Biol"},{"key":"8104_CR104","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1016427","volume":"13","author":"MV Legorreta-Haquet","year":"2022","unstructured":"Legorreta-Haquet MV, Santana-Sanchez P, Chavez-Sanchez L, Chavez-Rueda AK. The effect of prolactin on immune cell subsets involved in SLE pathogenesis. Front Immunol. 2022;13:1016427.","journal-title":"Front Immunol"},{"key":"8104_CR105","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1210\/en.2019-00073","volume":"160","author":"JH Shin","year":"2019","unstructured":"Shin JH, Seeley RJ. Reg3 proteins as gut hormones?. Endocrinology. 2019;160:1506\u201314.","journal-title":"Endocrinology"},{"key":"8104_CR106","doi-asserted-by":"publisher","first-page":"378","DOI":"10.2174\/1567202611666140912115107","volume":"11","author":"K Maiese","year":"2014","unstructured":"Maiese K. WISP1: clinical insights for a proliferative and restorative member of the CCN family. Curr Neurovasc Res. 2014;11:378\u201389.","journal-title":"Curr Neurovasc Res"},{"key":"8104_CR107","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1167\/iovs.65.6.31","volume":"65","author":"TAC de Guimaraes","year":"2024","unstructured":"de Guimaraes TAC, Kalitzeos A, Mahroo OA, van der Spuy J, Webster AR, Michaelides M. A long-term retrospective natural history study of EFEMP1-associated autosomal dominant drusen. Investig Ophthalmol Vis Sci. 2024;65:31.","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"8104_CR108","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.1016\/j.ophtha.2020.04.008","volume":"127","author":"N Pontikos","year":"2020","unstructured":"Pontikos N, Arno G, Jurkute N, Schiff E, Ba-Abbad R, Malka S, et al. Genetic basis of inherited retinal disease in a molecularly characterized cohort of more than 3000 families from the United Kingdom. Ophthalmology. 2020;127:1384\u201394.","journal-title":"Ophthalmology"},{"key":"8104_CR109","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1038\/nm.3806","volume":"21","author":"RC Coll","year":"2015","unstructured":"Coll RC, Robertson AA, Chae JJ, Higgins SC, Munoz-Planillo R, Inserra MC, et al. A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases. Nat Med. 2015;21:248\u201355.","journal-title":"Nat Med"},{"key":"8104_CR110","doi-asserted-by":"publisher","first-page":"2538","DOI":"10.3389\/fimmu.2019.02538","volume":"10","author":"A Zahid","year":"2019","unstructured":"Zahid A, Li B, Kombe AJK, Jin T, Tao J. Pharmacological inhibitors of the NLRP3 inflammasome. Front Immunol. 2019;10:2538.","journal-title":"Front Immunol"},{"key":"8104_CR111","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1038\/nrd.2018.149","volume":"17","author":"MSJ Mangan","year":"2018","unstructured":"Mangan MSJ, Olhava EJ, Roush WR, Seidel HM, Glick GD, Latz E. Targeting the NLRP3 inflammasome in inflammatory diseases. Nat Rev Drug Discov. 2018;17:688.","journal-title":"Nat Rev Drug Discov"},{"key":"8104_CR112","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1111\/cts.13576","volume":"16","author":"F Tang","year":"2023","unstructured":"Tang F, Kunder R, Chu T, Hains A, Nguyen A, McBride JM, et al. First-in-human phase 1 trial evaluating safety, pharmacokinetics, and pharmacodynamics of NLRP3 inflammasome inhibitor, GDC-2394, in healthy volunteers. Clin Transl Sci. 2023;16:1653\u201366.","journal-title":"Clin Transl Sci"},{"key":"8104_CR113","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-17634-1","volume":"8","author":"C Kosmidou","year":"2018","unstructured":"Kosmidou C, Efstathiou NE, Hoang MV, Notomi S, Konstantinou EK, Hirano M, et al. Issues with the specificity of immunological reagents for NLRP3: Implications for age-related macular degeneration. Sci Rep. 2018;8:461.","journal-title":"Sci Rep"},{"key":"8104_CR114","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1002\/eji.200940207","volume":"40","author":"SL Cassel","year":"2010","unstructured":"Cassel SL, Sutterwala FS. Sterile inflammatory responses mediated by the NLRP3 inflammasome. Eur J Immunol. 2010;40:607\u201311.","journal-title":"Eur J Immunol"},{"key":"8104_CR115","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.896353","volume":"13","author":"SK Banerjee","year":"2022","unstructured":"Banerjee SK, Chatterjee A, Gupta S, Nagar A. Activation and regulation of NLRP3 by sterile and infectious insults. Front Immunol. 2022;13:896353.","journal-title":"Front Immunol"},{"key":"8104_CR116","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-46116-9","volume":"9","author":"H Shimizu","year":"2019","unstructured":"Shimizu H, Sakimoto T, Yamagami S. Pro-inflammatory role of NLRP3 inflammasome in experimental sterile corneal inflammation. Sci Rep. 2019;9:9596.","journal-title":"Sci Rep"},{"key":"8104_CR117","doi-asserted-by":"publisher","first-page":"3473","DOI":"10.1182\/blood-2013-05-502229","volume":"122","author":"E Asgari","year":"2013","unstructured":"Asgari E, Le Friec G, Yamamoto H, Perucha E, Sacks SS, Kohl J, et al. C3a modulates IL-1beta secretion in human monocytes by regulating ATP efflux and subsequent NLRP3 inflammasome activation. Blood. 2013;122:3473\u201381.","journal-title":"Blood"},{"key":"8104_CR118","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.ophtha.2019.07.011","volume":"127","author":"DS Liao","year":"2020","unstructured":"Liao DS, Grossi FV, El Mehdi D, Gerber MR, Brown DM, Heier JS, et al. Complement C3 inhibitor pegcetacoplan for geographic atrophy secondary to age-related macular degeneration: a randomized phase 2 trial. Ophthalmology. 2020;127:186\u201395.","journal-title":"Ophthalmology"},{"key":"8104_CR119","doi-asserted-by":"publisher","first-page":"2837","DOI":"10.4049\/jimmunol.1302484","volume":"192","author":"EO Samstad","year":"2014","unstructured":"Samstad EO, Niyonzima N, Nymo S, Aune MH, Ryan L, Bakke SS, et al. Cholesterol crystals induce complement-dependent inflammasome activation and cytokine release. J Immunol. 2014;192:2837\u201345.","journal-title":"J Immunol"},{"key":"8104_CR120","doi-asserted-by":"publisher","DOI":"10.1016\/j.exer.2020.108204","volume":"200","author":"AP Voigt","year":"2020","unstructured":"Voigt AP, Whitmore SS, Lessing ND, DeLuca AP, Tucker BA, Stone EM, et al. Spectacle: an interactive resource for ocular single-cell RNA sequencing data analysis. Exp Eye Res. 2020;200:108204.","journal-title":"Exp Eye Res"},{"key":"8104_CR121","doi-asserted-by":"publisher","first-page":"2472","DOI":"10.1038\/s41423-021-00751-3","volume":"18","author":"JD Crapser","year":"2021","unstructured":"Crapser JD, Arreola MA, Tsourmas KI, Green KN. Microglia as hackers of the matrix: sculpting synapses and the extracellular space. Cell Mol Immunol. 2021;18:2472\u201388.","journal-title":"Cell Mol Immunol"},{"key":"8104_CR122","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/j.cell.2020.05.050","volume":"182","author":"PT Nguyen","year":"2020","unstructured":"Nguyen PT, Dorman LC, Pan S, Vainchtein ID, Han RT, Nakao-Inoue H, et al. Microglial remodeling of the extracellular matrix promotes synapse plasticity. Cell. 2020;182:388\u2013403.e315.","journal-title":"Cell"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-08104-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-08104-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-08104-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T17:02:26Z","timestamp":1762448546000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-08104-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,6]]},"references-count":122,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["8104"],"URL":"https:\/\/doi.org\/10.1038\/s41419-025-08104-y","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,6]]},"assertion":[{"value":"30 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 November 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All procedures were conducted under an Institutional Animal Care and Use Committee (IACUC)-approved animal protocol (#2016-101740 at UT Southwestern, #2308-41350A at UMN) and followed the ARVO guidelines for the \u201cUse of Animals in Ophthalmic and Vision Research\u201d.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}],"article-number":"803"}}